Patents by Inventor Ian Antheni MYLES

Ian Antheni MYLES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10195236
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: February 5, 2019
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • Publication number: 20180360891
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: July 23, 2018
    Publication date: December 20, 2018
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • Publication number: 20180296612
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: June 21, 2018
    Publication date: October 18, 2018
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • Publication number: 20180214495
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: March 28, 2018
    Publication date: August 2, 2018
    Inventors: Ian Antheni MYLES, Sandip K. DATTA